Injection Pen Market – Global Industry Analysis and Forecast (2019-2026) – By Type, Application, End Use and Region.

Injection Pen Market – Global Industry Analysis and Forecast (2019-2026) – By Type, Application, End Use and Region.

Market Scenario

Injection Pen Market is estimated to reach US$ XX Mn by 2026 in terms of revenue at a CAGR of XX % in the forecast Period. Injection Pen Market Injection pens are widely used in a variety of therapeutic applications, such as diabetes and osteoporosis, as they offer a variety of benefits over the normal flask and syringe methodology. For example, insulin pen devices improve patient satisfaction and adherence. It is simple to use and provides accuracy in delivering small amounts of insulin. Injection pen is user-friendly as the little needle sizes cut back to worry and pain and therefore has larger social acceptability. Patent expiry of biologics does drive the demand for biosimilars to push the growth opportunity for Injection Pen Market The key driving forces such as the rise in prevalence of chronic diseases, increase in a range of restrictive approvals, favorable compensation and government support drive the growth of the injection pen market. However, preference for various drug delivery modes and poor reimbursement scenario in developing countries is expected to restrain the growth of Injection Pen Market to a certain extent. Injection Pen Market is majorly segmented by type, therapy, end-user and region. Based on the type, the market is segmented into disposable and reusable injection pens. The disposable injection pens segment is expected to grow at the highest CAGR during the forecast period. This can be attributed to the benefits that these pens offer, such as portability, ease of use, and a lower possibility of infection. Based on therapy, the global Injection Pen Market is segmented into diabetes, growth hormone therapy, osteoporosis, fertility, and other therapies. The diabetes segment is expected to grow at the highest CAGR during the forecast period. The high growth of the segment can be mostly attributed to the large diabetic population and favorable reimbursements for diabetic treatments in developed countries. The diabetes segment is further segmented into Insulin and GLP-1. The North America region holds a major market share and is predominantly driven by factors such as the rising prevalence of diabetes in the US and Canada, a favorable reimbursement scenario, and the increase in number of awareness programs in the region. The Asia-Pacific region is expected to witness a significant growth during the forecast period as compared to the developed markets due to the huge patient pool with chronic diseases and increasing healthcare expenditure. For instance, according to WHO (2016), in China, 10% of adults were diagnosed with diabetes. It also stated that type 2 diabetes was found to be the most prevalent type of diabetes in China. Injection Pen Market share is consolidated, as the key multinational players occupy the major industry share. Novo Nordisk (Denmark), Eli Lilly (US), Sanofi (France), Merck (US), Ypsomed (Switzerland), AstraZeneca (UK), F. Hoffman-La Roche (Switzerland), Becton Dickinson and Company (US), Owen Mumford (UK), Novartis (Switzerland), Pfizer (US), and Haselmeier (Switzerland) are some of the major industry players. Production capacity expansion, brand portfolio expansion, mergers, collaborations, and acquisitions are the key strategies adopted by industry players.

Injection Pen Market Report Scope:

The market covered in this report has been segmented as follows:

Injection Pen Market, By Type

• Disposable injection pens • Reusable injection pens

Injection Pen Market, By End Users

• Home care • Hospital & clinics

Injection Pen Market, By Disease and Disorder

• Diabetes o Insulin o GLP-1 • Growth hormone therapy • Fertility • Osteoporosis • Other therapies (multiple sclerosis, cardiovascular diseases, migraines, rheumatoid arthritis, obesity, Crohn's disease, and cancer)

Injection Pen Market, By Region

• North America • Europe • Asia Pacific • Rest of the World

Key Players operating in the market:

• Novo Nordisk • Eli Lilly • Sanofi • Merck • Ypsomed • AstraZeneca • F. Hoffman-La Roche • Becton Dickinson and Company • Owen Mumford • Novartis • Pfizer • Haselmeier Maximize Market Research, a global market research firm with a dedicated team of specialists and data has carried out extensive research about the current Injection Pen Market outlook. The report encompasses the Injection Pen Market by different segments and region, providing the in-depth analysis of the overall industry ecosystem, useful for taking the informed strategic decision by the key stakeholders in the industry. Importantly, the report delivers forecasts and share of the injection Pen Market, further giving an insight into the market dynamics, and future opportunities that might exist in the Injection Pen Market. The driving forces, as well as considerable restraints, have been explained in depth. In addition to this, competitive landscape describing the strategic growth of the competitors have been taken into consideration for enhancing market know-how of our clients and at the same time explain Injection Pen Market positioning of competitors. Global Medical Holography Market

Table of Contents

Global Injection Pen Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Injection Pen Market Size, by Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Injection Pen Market Analysis and Forecast 6.1. Global Injection Pen Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Injection Pen Market Analysis and Forecast, by Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Injection Pen Market Value Share Analysis, by Type 7.4. Global Injection Pen Market Size (US$ Mn) Forecast, by Type 7.5. Global Injection Pen Market Analysis, by Type 7.6. Global Injection Pen Market Attractiveness Analysis, by Type 8. Global Injection Pen Market Analysis and Forecast, by End Users 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Injection Pen Market Value Share Analysis, by End Users 8.4. Global Injection Pen Market Size (US$ Mn) Forecast, by End Users 8.5. Global Injection Pen Market Analysis, by End Users 8.6. Global Injection Pen Market Attractiveness Analysis, by End Users 9. Global Injection Pen Market Analysis and Forecast, by Disease and Disorder 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Injection Pen Market Value Share Analysis, by Disease and Disorder 9.4. Global Injection Pen Market Size (US$ Mn) Forecast, by Disease and Disorder 9.5. Global Injection Pen Market Analysis, by Disease and Disorder 9.6. Global Injection Pen Market Attractiveness Analysis, by Disease and Disorder 10. Global Injection Pen Market Analysis, by Region 10.1. Global Injection Pen Market Value Share Analysis, by Region 10.2. Global Injection Pen Market Size (US$ Mn) Forecast, by Region 10.3. Global Injection Pen Market Attractiveness Analysis, by Region 11. North America Injection Pen Market Analysis 11.1. Key Findings 11.2. North America Injection Pen Market Overview 11.3. North America Injection Pen Market Value Share Analysis, by Type 11.4. North America Injection Pen Market Forecast, by Type 11.4.1. Disposable injection pens 11.4.2. Reusable injection pens 11.5. North America Injection Pen Market Value Share Analysis, by End Users 11.6. North America Injection Pen Market Forecast, by End Users 11.6.1. Home care 11.6.2. Hospital & clinics 11.7. North America Injection Pen Market Value Share Analysis, by Disease and Disorder 11.8. North America Injection Pen Market Forecast, by Disease and Disorder 11.8.1. Diabetes 11.8.2. Insulin 11.8.3. GLP-1 11.8.4. Growth hormone therapy 11.8.5. Fertility 11.8.6. Osteoporosis 11.8.7. Other therapies (multiple sclerosis, cardiovascular diseases, migraines, rheumatoid arthritis, obesity, Crohn's disease, and cancer) 11.9. North America Injection Pen Market Value Share Analysis, by Country 11.10. North America Injection Pen Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Injection Pen Market Analysis, by Country 11.12. U.S. Injection Pen Market Forecast, by Type 11.12.1. Disposable injection pens 11.12.2. Reusable injection pens 11.13. U.S. Injection Pen Market Forecast, by End Users 11.13.1. Home care 11.13.2. Hospital & clinics 11.14. U.S. Injection Pen Market Forecast, by Disease and Disorder 11.14.1. Diabetes 11.14.2. Insulin 11.14.3. GLP-1 11.14.4. Growth hormone therapy 11.14.5. Fertility 11.14.6. Osteoporosis 11.14.7. Other therapies (multiple sclerosis, cardiovascular diseases, migraines, rheumatoid arthritis, obesity, Crohn's disease, and cancer) 11.15. Canada Injection Pen Market Forecast, by Type 11.15.1. Disposable injection pens 11.15.2. Reusable injection pens 11.16. Canada Injection Pen Market Forecast, by End Users 11.16.1. Home care 11.16.2. Hospital & clinics 11.17. Canada Injection Pen Market Forecast, by Disease and Disorder 11.17.1. Diabetes 11.17.2. Insulin 11.17.3. GLP-1 11.17.4. Growth hormone therapy 11.17.5. Fertility 11.17.6. Osteoporosis 11.17.7. Other therapies (multiple sclerosis, cardiovascular diseases, migraines, rheumatoid arthritis, obesity, Crohn's disease, and cancer) 11.18. North America Injection Pen Market Attractiveness Analysis 11.18.1. By Type 11.18.2. By End Users 11.18.3. By Disease and Disorder 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Injection Pen Market Analysis 12.1. Key Findings 12.2. Europe Injection Pen Market Overview 12.3. Europe Injection Pen Market Value Share Analysis, by Type 12.4. Europe Injection Pen Market Forecast, by Type 12.4.1. Disposable injection pens 12.4.2. Reusable injection pens 12.5. Europe Injection Pen Market Value Share Analysis, by End Users 12.6. Europe Injection Pen Market Forecast, by End Users 12.6.1. Home care 12.6.2. Hospital & clinics 12.7. Europe Injection Pen Market Value Share Analysis, by Disease and Disorder 12.8. Europe Injection Pen Market Forecast, by Disease and Disorder 12.8.1. Foundation Fieldbus and Hart 12.8.2. Profibus 12.8.3. Profinet 12.8.4. Ethernet/IP 12.8.5. Modbus 12.8.6. Others 12.9. Europe Injection Pen Market Value Share Analysis, by Country 12.10. Europe Injection Pen Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Injection Pen Market Analysis, by Country 12.12. Germany Injection Pen Market Forecast, by Type 12.12.1. Disposable injection pens 12.12.2. Reusable injection pens 12.13. Germany Injection Pen Market Forecast, by End Users 12.13.1. Home care 12.13.2. Hospital & clinics 12.14. Germany Injection Pen Market Forecast, by Disease and Disorder 12.14.1. Diabetes 12.14.2. Insulin 12.14.3. GLP-1 12.14.4. Growth hormone therapy 12.14.5. Fertility 12.14.6. Osteoporosis 12.14.7. Other therapies (multiple sclerosis, cardiovascular diseases, migraines, rheumatoid arthritis, obesity, Crohn's disease, and cancer) 12.15. U.K. Injection Pen Market Forecast, by Type 12.15.1. Disposable injection pens 12.15.2. Reusable injection pens 12.16. U.K. Injection Pen Market Forecast, by End Users 12.16.1. Home care 12.16.2. Hospital & clinics 12.17. U.K. Injection Pen Market Forecast, by Disease and Disorder 12.17.1. Foundation Fieldbus and Hart 12.17.2. Profibus 12.17.3. Profinet 12.17.4. Ethernet/IP 12.17.5. Modbus 12.17.6. Others 12.18. France Injection Pen Market Forecast, by Type 12.18.1. Disposable injection pens 12.18.2. Reusable injection pens 12.19. France Injection Pen Market Forecast, by End Users 12.19.1. Home care 12.19.2. Hospital & clinics 12.20. France Injection Pen Market Forecast, by Disease and Disorder 12.20.1. Diabetes 12.20.2. Insulin 12.20.3. GLP-1 12.20.4. Growth hormone therapy 12.20.5. Fertility 12.20.6. Osteoporosis 12.20.7. Other therapies (multiple sclerosis, cardiovascular diseases, migraines, rheumatoid arthritis, obesity, Crohn's disease, and cancer) 12.21. Italy Injection Pen Market Forecast, by Type 12.21.1. Disposable injection pens 12.21.2. Reusable injection pens 12.22. Italy Injection Pen Market Forecast, by End Users 12.22.1. Home care 12.22.2. Hospital & clinics 12.23. Italy Injection Pen Market Forecast, by Disease and Disorder 12.23.1. Diabetes 12.23.2. Insulin 12.23.3. GLP-1 12.23.4. Growth hormone therapy 12.23.5. Fertility 12.23.6. Osteoporosis 12.23.7. Other therapies (multiple sclerosis, cardiovascular diseases, migraines, rheumatoid arthritis, obesity, Crohn's disease, and cancer) 12.24. Spain Injection Pen Market Forecast, by Type 12.24.1. Disposable injection pens 12.24.2. Reusable injection pens 12.25. Spain Injection Pen Market Forecast, by End Users 12.25.1. Home care 12.25.2. Hospital & clinics 12.26. Spain Injection Pen Market Forecast, by Disease and Disorder 12.26.1. Diabetes 12.26.2. Insulin 12.26.3. GLP-1 12.26.4. Growth hormone therapy 12.26.5. Fertility 12.26.6. Osteoporosis 12.26.7. Other therapies (multiple sclerosis, cardiovascular diseases, migraines, rheumatoid arthritis, obesity, Crohn's disease, and cancer) 12.27. Rest of Europe Injection Pen Market Forecast, by Type 12.27.1. Disposable injection pens 12.27.2. Reusable injection pens 12.28. Rest of Europe Injection Pen Market Forecast, by End Users 12.28.1. Home care 12.28.2. Hospital & clinics 12.29. Rest of Europe Injection Pen Market Forecast, by Disease and Disorder 12.29.1. Diabetes 12.29.2. Insulin 12.29.3. GLP-1 12.29.4. Growth hormone therapy 12.29.5. Fertility 12.29.6. Osteoporosis 12.29.7. Other therapies (multiple sclerosis, cardiovascular diseases, migraines, rheumatoid arthritis, obesity, Crohn's disease, and cancer) 12.30. Europe Injection Pen Market Attractiveness Analysis 12.30.1. By Type 12.30.2. By End Users 12.30.3. By Disease and Disorder 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Injection Pen Market Analysis 13.1. Key Findings 13.2. Asia Pacific Injection Pen Market Overview 13.3. Asia Pacific Injection Pen Market Value Share Analysis, by Type 13.4. Asia Pacific Injection Pen Market Forecast, by Type 13.4.1. Disposable injection pens 13.4.2. Reusable injection pens 13.5. Asia Pacific Injection Pen Market Value Share Analysis, by End Users 13.6. Asia Pacific Injection Pen Market Forecast, by End Users 13.6.1. Home care 13.6.2. Hospital & clinics 13.7. Asia Pacific Injection Pen Market Value Share Analysis, by Disease and Disorder 13.8. Asia Pacific Injection Pen Market Forecast, by Disease and Disorder 13.8.1. Diabetes 13.8.2. Insulin 13.8.3. GLP-1 13.8.4. Growth hormone therapy 13.8.5. Fertility 13.8.6. Osteoporosis 13.8.7. Other therapies (multiple sclerosis, cardiovascular diseases, migraines, rheumatoid arthritis, obesity, Crohn's disease, and cancer) 13.9. Asia Pacific Injection Pen Market Value Share Analysis, by Country 13.10. Asia Pacific Injection Pen Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Injection Pen Market Analysis, by Country 13.12. China Injection Pen Market Forecast, by Type 13.12.1. Disposable injection pens 13.12.2. Reusable injection pens 13.13. China Injection Pen Market Forecast, by End Users 13.13.1. Home care 13.13.2. Hospital & clinics 13.14. China Injection Pen Market Forecast, by Disease and Disorder 13.14.1. Diabetes 13.14.2. Insulin 13.14.3. GLP-1 13.14.4. Growth hormone therapy 13.14.5. Fertility 13.14.6. Osteoporosis 13.14.7. Other therapies (multiple sclerosis, cardiovascular diseases, migraines, rheumatoid arthritis, obesity, Crohn's disease, and cancer) 13.15. India Injection Pen Market Forecast, by Type 13.15.1. Disposable injection pens 13.15.2. Reusable injection pens 13.16. India Injection Pen Market Forecast, by End Users 13.16.1. Home care 13.16.2. Hospital & clinics 13.17. India Injection Pen Market Forecast, by Disease and Disorder 13.17.1. Diabetes 13.17.2. Insulin 13.17.3. GLP-1 13.17.4. Growth hormone therapy 13.17.5. Fertility 13.17.6. Osteoporosis 13.17.7. Other therapies (multiple sclerosis, cardiovascular diseases, migraines, rheumatoid arthritis, obesity, Crohn's disease, and cancer) 13.18. Japan Injection Pen Market Forecast, by Type 13.18.1. Disposable injection pens 13.18.2. Reusable injection pens 13.19. Japan Injection Pen Market Forecast, by End Users 13.19.1. Home care 13.19.2. Hospital & clinics 13.20. Japan Injection Pen Market Forecast, by Disease and Disorder 13.20.1. Diabetes 13.20.2. Insulin 13.20.3. GLP-1 13.20.4. Growth hormone therapy 13.20.5. Fertility 13.20.6. Osteoporosis 13.20.7. Other therapies (multiple sclerosis, cardiovascular diseases, migraines, rheumatoid arthritis, obesity, Crohn's disease, and cancer) 13.21. ASEAN Injection Pen Market Forecast, by Type 13.21.1. Disposable injection pens 13.21.2. Reusable injection pens 13.22. ASEAN Injection Pen Market Forecast, by End Users 13.22.1. Home care 13.22.2. Hospital & clinics 13.23. ASEAN Injection Pen Market Forecast, by Disease and Disorder 13.23.1. Diabetes 13.23.2. Insulin 13.23.3. GLP-1 13.23.4. Growth hormone therapy 13.23.5. Fertility 13.23.6. Osteoporosis 13.23.7. Other therapies (multiple sclerosis, cardiovascular diseases, migraines, rheumatoid arthritis, obesity, Crohn's disease, and cancer) 13.24. Rest of Asia Pacific Injection Pen Market Forecast, by Type 13.24.1. Disposable injection pens 13.24.2. Reusable injection pens 13.25. Rest of Asia Pacific Injection Pen Market Forecast, by End Users 13.25.1. Home care 13.25.2. Hospital & clinics 13.26. Rest of Asia Pacific Injection Pen Market Forecast, by Disease and Disorder 13.26.1. Diabetes 13.26.2. Insulin 13.26.3. GLP-1 13.26.4. Growth hormone therapy 13.26.5. Fertility 13.26.6. Osteoporosis 13.26.7. Other therapies (multiple sclerosis, cardiovascular diseases, migraines, rheumatoid arthritis, obesity, Crohn's disease, and cancer) 13.27. Asia Pacific Injection Pen Market Attractiveness Analysis 13.27.1. By Type 13.27.2. By End Users 13.27.3. By Disease and Disorder 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Injection Pen Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Injection Pen Market Overview 14.3. Middle East & Africa Injection Pen Market Value Share Analysis, by Type 14.4. Middle East & Africa Injection Pen Market Forecast, by Type 14.4.1. Disposable injection pens 14.4.2. Reusable injection pens 14.5. Middle East & Africa Injection Pen Market Value Share Analysis, by End Users 14.6. Middle East & Africa Injection Pen Market Forecast, by End Users 14.6.1. Home care 14.6.2. Hospital & clinics 14.7. Middle East & Africa Injection Pen Market Value Share Analysis, by Disease and Disorder 14.8. Middle East & Africa Injection Pen Market Forecast, by Disease and Disorder 14.8.1. Diabetes 14.8.2. Insulin 14.8.3. GLP-1 14.8.4. Growth hormone therapy 14.8.5. Fertility 14.8.6. Osteoporosis 14.8.7. Other therapies (multiple sclerosis, cardiovascular diseases, migraines, rheumatoid arthritis, obesity, Crohn's disease, and cancer) 14.9. Middle East & Africa Injection Pen Market Value Share Analysis, by Country 14.10. Middle East & Africa Injection Pen Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Injection Pen Market Analysis, by Country 14.12. GCC Injection Pen Market Forecast, by Type 14.12.1. Disposable injection pens 14.12.2. Reusable injection pens 14.13. GCC Injection Pen Market Forecast, by End Users 14.13.1. Home care 14.13.2. Hospital & clinics 14.14. GCC Injection Pen Market Forecast, by Disease and Disorder 14.14.1. Diabetes 14.14.2. Insulin 14.14.3. GLP-1 14.14.4. Growth hormone therapy 14.14.5. Fertility 14.14.6. Osteoporosis 14.14.7. Other therapies (multiple sclerosis, cardiovascular diseases, migraines, rheumatoid arthritis, obesity, Crohn's disease, and cancer) 14.15. South Africa Injection Pen Market Forecast, by Type 14.15.1. Disposable injection pens 14.15.2. Reusable injection pens 14.16. South Africa Injection Pen Market Forecast, by End Users 14.16.1. Home care 14.16.2. Hospital & clinics 14.17. South Africa Injection Pen Market Forecast, by Disease and Disorder 14.17.1. Diabetes 14.17.2. Insulin 14.17.3. GLP-1 14.17.4. Growth hormone therapy 14.17.5. Fertility 14.17.6. Osteoporosis 14.17.7. Other therapies (multiple sclerosis, cardiovascular diseases, migraines, rheumatoid arthritis, obesity, Crohn's disease, and cancer) 14.18. Rest of Middle East & Africa Injection Pen Market Forecast, by Type 14.18.1. Disposable injection pens 14.18.2. Reusable injection pens 14.19. Rest of Middle East & Africa Injection Pen Market Forecast, by End Users 14.19.1. Home care 14.19.2. Hospital & clinics 14.20. Rest of Middle East & Africa Injection Pen Market Forecast, by Disease and Disorder 14.20.1. Diabetes 14.20.2. Insulin 14.20.3. GLP-1 14.20.4. Growth hormone therapy 14.20.5. Fertility 14.20.6. Osteoporosis 14.20.7. Other therapies (multiple sclerosis, cardiovascular diseases, migraines, rheumatoid arthritis, obesity, Crohn's disease, and cancer) 14.21. Middle East & Africa Injection Pen Market Attractiveness Analysis 14.21.1. By Type 14.21.2. By End Users 14.21.3. By Disease and Disorder 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Injection Pen Market Analysis 15.1. Key Findings 15.2. South America Injection Pen Market Overview 15.3. South America Injection Pen Market Value Share Analysis, by Type 15.4. South America Injection Pen Market Forecast, by Type 15.4.1. Disposable injection pens 15.4.2. Reusable injection pens 15.5. South America Injection Pen Market Value Share Analysis, by End Users 15.6. South America Injection Pen Market Forecast, by End Users 15.6.1. Home care 15.6.2. Hospital & clinics 15.7. South America Injection Pen Market Value Share Analysis, by Disease and Disorder 15.8. South America Injection Pen Market Forecast, by Disease and Disorder 15.8.1. Diabetes 15.8.2. Insulin 15.8.3. GLP-1 15.8.4. Growth hormone therapy 15.8.5. Fertility 15.8.6. Osteoporosis 15.8.7. Other therapies (multiple sclerosis, cardiovascular diseases, migraines, rheumatoid arthritis, obesity, Crohn's disease, and cancer) 15.9. South America Injection Pen Market Value Share Analysis, by Country 15.10. South America Injection Pen Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Injection Pen Market Analysis, by Country 15.12. Brazil Injection Pen Market Forecast, by Type 15.12.1. Disposable injection pens 15.12.2. Reusable injection pens 15.13. Brazil Injection Pen Market Forecast, by End Users 15.13.1. Home care 15.13.2. Hospital & clinics 15.14. Brazil Injection Pen Market Forecast, by Disease and Disorder 15.14.1. Diabetes 15.14.2. Insulin 15.14.3. GLP-1 15.14.4. Growth hormone therapy 15.14.5. Fertility 15.14.6. Osteoporosis 15.14.7. Other therapies (multiple sclerosis, cardiovascular diseases, migraines, rheumatoid arthritis, obesity, Crohn's disease, and cancer) 15.15. Mexico Injection Pen Market Forecast, by Type 15.15.1. Disposable injection pens 15.15.2. Reusable injection pens 15.16. Mexico Injection Pen Market Forecast, by End Users 15.16.1. Home care 15.16.2. Hospital & clinics 15.17. Mexico Injection Pen Market Forecast, by Disease and Disorder 15.17.1. Diabetes 15.17.2. Insulin 15.17.3. GLP-1 15.17.4. Growth hormone therapy 15.17.5. Fertility 15.17.6. Osteoporosis 15.17.7. Other therapies (multiple sclerosis, cardiovascular diseases, migraines, rheumatoid arthritis, obesity, Crohn's disease, and cancer) 15.18. Rest of South America Injection Pen Market Forecast, by Type 15.18.1. Disposable injection pens 15.18.2. Reusable injection pens 15.19. Rest of South America Injection Pen Market Forecast, by End Users 15.19.1. Home care 15.19.2. Hospital & clinics 15.20. Rest of South America Injection Pen Market Forecast, by Disease and Disorder 15.20.1. Diabetes 15.20.2. Insulin 15.20.3. GLP-1 15.20.4. Growth hormone therapy 15.20.5. Fertility 15.20.6. Osteoporosis 15.20.7. Other therapies (multiple sclerosis, cardiovascular diseases, migraines, rheumatoid arthritis, obesity, Crohn's disease, and cancer) 15.21. South America Injection Pen Market Attractiveness Analysis 15.21.1. By Type 15.21.2. By End Users 15.21.3. By Disease and Disorder 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Novo Nordisk 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Development Footprint 16.3.2. Eli Lilly 16.3.3. Sanofi 16.3.4. Merck 16.3.5. Ypsomed 16.3.6. AstraZeneca 16.3.7. F. Hoffman-La Roche 16.3.8. Becton Dickinson and Company 16.3.9. Owen Mumford 16.3.10. Novartis 16.3.11. Pfizer 16.3.12. Haselmeier 17. Primary Key Insights

About This Report

Report ID11865
Published Date
Contact Us
Call Now